González-Longoria BLB

Language: Spanish
References: 13
Page: 1899-1905
PDF size: 192.37 Kb.

ABSTRACT

A descriptive and longitudinal study of 273 women with breast cancer belonging to Granma province was carried out from 2003 to 2004, in order to analyze the survival of this female population, reason why the method of Kaplan Meier was used for the calculation of the mentioned variable an d the Log Rank test was used for the comparison of curves. Patients with higher survival at 5 years were those who had tumors of 2 cm or less (87.5%), histological grade I (90.3%), nuclear grade I (88.3%), as well as the absence of vascula r, lymphatic or lymph node invasion (with 80.6; 74.9 and 6.1% respectively). Also, tumor size, histological and nuclear grade, nodal status, as well as lymphatic and vascul ar invasion constituted prognosis factors, which favored the individualization of therapeutic behaviors.

REFERENCES

1. Cáncer: Generalidades. [citado 25 Ago 2009] Disponible en: http://salud.discapnet.es/Castellano/Sal ud/Enciclopedia/C/Paginas/Cancer%20gen eralidades.aspx

2. Cáncer. [citado 25 Ago 2009] Disponible en: http://es.wikipedia.org/wiki/C%C3%A1ncer

3. Jemal A, Center MM, DeSantis C, Ward EM. Global patterns of cancer incidence and mortality rates and trends. Cancer Ep idemiol Biomarkers Prev. 2010;19(8):1893- 7.

4. Ferlay J, Shin HR, Bray F, Forman D, Mathers C, Parkin DM. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer. 2010; 127(12):2893–917.

5. Cuba. Ministerio de Salud Pública. Anuario Estadístico de Salud 2010. La Habana: MINSAP, Dirección Nacional de Registros Médicos y Estadísticas de Salud. [citado 30 Nov 2011]. Disponible en: http://files.sld.cu/dne/fi les/2011/04/anuario-2010- e-sin-graficos1.pdf

6. Cuba. Dirección Provincial de Salud. Departamento de Estadística. Granma;2008.

7. Kummel S, Rezai M, Kimmig R, Schmid P. Dose dense chemotherapy for primary breast cancer. Curr Opin Obstet Gynecol. 2007;19(1):75-81.

8. Flores Luna L, Salazar Martínez E, Duarte Torres RM, Torres Mejía G, Alonso Ruíz P, Lazcano Ponce E. Factores pronósticos relacionados con la supervivencia del cáncer de mama. Salud Pú blica Mex. 2008;50(2):119-25.

9. Zepeda Castilla EJ, Recinos Money E, Cu éllar Hubbe M, Robles Vidal CD, Maafs- Molina E. Clasificación molecular del cá ncer de mama. Cir Ciruj. 2008;76:87-93.

10. Kollias J, Elston CW, Ellis IO, Robertson JF, Blamey RW. Early-onset breast cancer: histopathological and prognostic consid erations. Br J Cancer. 1997;75(9):1318-23.

11. Domínguez MA, Marcos M, Meiriño R, Vill afranca E, Dueñas MT, Arias F, et al. Factores pronósticos y predictivos en el cáncer de mama temprano. Anales. 2001; 24(Supl 1):99-110.

12. Fitzgibbons PL, Page DL, Weaver D, Thor AD , Allred DC, Clark GM et al. Prognostic factors in breast cancer. College of American Pathologist Consensus Statement 1999. Arch Pathol Lab Med. 2000;124(7):966-78.

13. Álvarez Goyanes RI, Escobar Pérez X, Camacho Rodríguez R, Orozco López M, Franco Odio S, LLanes Fernández L, et al. Receptores hormonales y otros factores pronósticos en cáncer de mama en Cuba. Cancerología. 2008;3:19-27.